Dolutegravir (DTG) is the ART drug associated with an increased risk of neural tube defects (NTDs) if used during the periconception period. Neural tube defects are birth defects that affect the brain, spine, or spinal cord of a developing fetus. Studies have shown that women who were taking DTG at the time of conception or early pregnancy had a higher risk of having a child with NTDs compared to women taking other ART drugs.

This increased risk has led to recommendations for careful counseling and consideration of alternative regimens for women of childbearing potential who are taking DTG. It is important for healthcare providers to discuss the potential risks and benefits of DTG with their patients and to consider switching to a different ART drug if pregnancy is planned or possible. This can help to minimize the risk of NTDs and ensure the health and safety of both the mother and the developing fetus.

Listeria infection during pregnancy can have serious consequences for the fetus, with a fetal case mortality rate of 0.25. This means that 25% of fetuses affected by listeria infection do not survive. Listeria Monocytogenes is a bacteria that can be transmitted to the fetus through the placenta, leading to congenital infection. The most common source of the bacteria is contaminated food, particularly unpasteurised milk.

Congenital listeriosis can result in a range of complications for the fetus, including spontaneous abortions, premature birth, and chorioamnionitis. Neonates born with listeriosis may present with symptoms such as septicaemia, respiratory distress, and inflammatory granulomatosis. The overall case mortality rate for listeriosis is estimated to be between 20-30%, highlighting the severity of this infection during pregnancy.

Abacavir (ABC) hypersensitivity reaction is a potentially life-threatening allergic reaction that can occur in individuals who are HLA-B*5701 positive. Symptoms of ABC hypersensitivity reaction can include fever, rash, gastrointestinal symptoms, respiratory symptoms, and constitutional symptoms. If a client on an NNRTI-based regimen develops symptoms suggestive of ABC hypersensitivity reaction, it is crucial to discontinue all ART medications immediately to prevent further adverse reactions.

Switching to an integrase inhibitor-based regimen is not the recommended action in this scenario, as the priority is to address the hypersensitivity reaction to ABC. Discontinuing all ART medications is the appropriate immediate action to prevent further harm to the client. Initiating treatment for MDR-TB or performing HLA-B*5701 typing may be necessary in certain situations, but the immediate focus should be on managing the hypersensitivity reaction.

Referring the client to a third-line review committee may be considered after the acute situation has been addressed, but the priority is to discontinue all ART medications and manage the hypersensitivity reaction. It is important to closely monitor the client, provide supportive care, and consider alternative ART options once the hypersensitivity reaction has been resolved.

Guidelines for HIV-positive mothers and breastfeeding

Breastfeeding is not recommended for HIV-positive mothers as it increases the risk of transmission to the child. Instead, the baby should receive a first dose of antiretroviral therapy within four hours of delivery and continue treatment for 4-6 weeks. Blood tests are taken at set intervals to check the baby’s status. Hepatitis B vaccination should be offered at birth only if there is co-infection with hepatitis B virus in the mother.

However, if the mother’s viral load is less than 50 copies/ml, breastfeeding may be considered in low-resource settings where the nutritive benefits outweigh the risk of transmission. In high-resource settings, breastfeeding is not advised. The baby will still need to undergo several blood tests to establish their HIV status, with the last one taking place at 18 months of life.

The patient has sickle cell disease and a history of recurrent infections, indicating long-term damage to the spleen. The blood film shows signs of splenic disruption, such as Howell-Jolly bodies, and a low lymphocyte level, which may be due to reduced lymphocyte storage capacity in the shrunken spleen. This is different from a splenic sequestration crisis, which is an acute pediatric emergency. The current admission may be an acute chest pain crisis, but it is not the cause of the recurrent infections. The patient does not have acute lymphoblastic leukemia, as there is no evidence of blastic cells or pancytopenia. Advanced HIV is a possibility, but the blood film suggests sickle cell disease. While the patient is at risk of an aplastic crisis, it typically occurs in younger patients after a parvovirus B19 infection, which is not present in this case.

Indeterminate HIV-PCR results in infants can be a cause for concern as it is unclear whether the infant is truly infected with HIV or not. In such cases, it is important to take immediate action to determine the infant’s HIV status and provide appropriate care.

The recommended approach for infants with indeterminate HIV-PCR results is to repeat both the HIV-PCR and HIV rapid test urgently. This is necessary to confirm the infant’s HIV status and ensure that appropriate treatment and care can be provided if the infant is indeed infected with HIV.

Initiating antiretroviral therapy (ART) immediately may be considered if the repeat tests confirm HIV infection. Discontinuing breastfeeding may also be necessary to prevent transmission of the virus to the infant. Administering high-risk infant prophylaxis can help reduce the risk of HIV transmission in cases where the infant’s HIV status is still uncertain.

It is important not to defer further testing until the infant is older, as early diagnosis and treatment of HIV in infants is crucial for their long-term health outcomes. Therefore, repeating both the HIV-PCR and HIV rapid test urgently is the recommended approach in cases of indeterminate HIV-PCR results in infants.

The guideline proposes using specific documents such as the Maternity Case Record for the mother and The Road to Health Booklet for the HIV-exposed infant because these documents are designed to capture all the necessary information related to the healthcare of HIV-positive women and their infants. These documents provide a structured format for recording important medical history, test results, treatment plans, and follow-up care. By using these specific documents, healthcare providers can ensure that all relevant information is documented accurately and consistently, which is essential for providing comprehensive and coordinated care to HIV-positive women and their infants. Additionally, using standardized documents like the Maternity Case Record and The Road to Health Booklet can facilitate communication and information sharing among healthcare providers, ultimately improving the quality of care for this vulnerable population.

Liver disease can have various causes, including viral infections like hepatitis B. It is important to investigate and manage these possible causes in order to provide appropriate treatment and care for the client.

The correct answer is Investigate and manage possible causes, including hepatitis B. This is the most appropriate action to take when a client presents with signs and symptoms of liver disease during the baseline clinical evaluation. By identifying and addressing the underlying cause of the liver disease, healthcare providers can better manage the client’s condition and provide the necessary treatment.

Varicella zoster, also known as chickenpox, is a viral infection that commonly affects children but can also occur in adults. It presents with symptoms such as fever, fatigue, and multiple lesions on the skin. These lesions typically start as red spots and progress to fluid-filled blisters before crusting over.

Herpes zoster, on the other hand, is caused by the reactivation of the varicella zoster virus in individuals who have previously had chickenpox. It presents as a painful rash with fluid-filled blisters, typically in a single dermatome.

Impetigo is a bacterial skin infection that presents with red sores or blisters that can burst and form a yellow crust. It is more common in children than adults.

Psoriasis is a chronic autoimmune condition that causes red, scaly patches on the skin. It is not typically associated with fever or fatigue.

In this case, the most probable diagnosis is varicella zoster, given the patient’s age, symptoms of fever and fatigue, and the presence of multiple lesions in various forms on the back and abdomen.

The most accurate statement regarding the administration of vaccines in children with HIV, according to the Advisory Committee on Immunization Practices (ACIP), is that most recommended routine childhood vaccines are safe for children with HIV, with the exception that children with severe immunosuppression (CD4 count less than 200 cells/mm3 and CD4 percentage less than 15%) should not receive varicella or measles-mumps-rubella (MMR). This means that children with HIV can receive most vaccines per standard recommended schedules, but certain live vaccines should be avoided in those with severe immunosuppression. It is important for healthcare providers to follow these guidelines to ensure the safety and effectiveness of vaccinations in children with HIV.

Atazanavir is a protease inhibitor commonly used in the treatment of HIV. One of the known side effects of atazanavir is jaundice, which can cause yellowing of the skin and sclerae. This side effect is typically seen within the first few weeks of starting the medication. In this case, the timing of the symptoms aligns with the initiation of atazanavir therapy, making it the most likely culprit.

It is important for patients to adhere to their ARV drug regimen in order to effectively manage their HIV infection. However, some patients may have difficulty swallowing whole tablets, which can make it challenging for them to take their medication as prescribed. In such cases, it is recommended to crush, split, or open capsules/tablets as necessary and as specified for certain drugs.

Forcing the patient to swallow whole tablets regardless of their ability can lead to non-adherence and potentially compromise the effectiveness of the treatment. Discontinuing the ARV medication or switching to an entirely new regimen may not be necessary if the issue can be resolved by modifying the administration of the medication.

The guidelines provide specific advice on whether ARV tablets/capsules can be split, crushed, or opened if a patient is unable to swallow them whole. This allows healthcare providers to ensure that patients can continue their treatment while addressing any difficulties they may have with swallowing whole tablets. By following these recommendations, patients can maintain adherence to their ARV drug regimen and effectively manage their HIV infection.

During pregnancy, routine screenings are important to ensure the health and well-being of both the mother and the baby. Syphilis screening is recommended because untreated syphilis can lead to serious complications for both the mother and the baby. Gonorrhea and chlamydia screenings are important to detect and treat these common sexually transmitted infections, which can also have negative effects on pregnancy. Tuberculosis screening is recommended to identify and treat active TB infections, which can be harmful during pregnancy.

Malaria screening, on the other hand, is not typically included in routine antenatal care screenings for pregnant women, unless they have traveled to or live in areas where malaria is endemic. Malaria can have serious consequences for pregnant women and their babies, but it is not considered a standard screening procedure in all settings. Therefore, the correct answer is Malaria screening.

The 22-year-old female likely developed a vaginal yeast infection caused by Candida albicans. This is a common occurrence after taking antibiotics, as the medication can disrupt the normal balance of bacteria and yeast in the body. Candida albicans is a type of fungus that is normally present in the vagina in small amounts. However, when the balance is disrupted, it can overgrow and lead to symptoms such as a whitish discharge.

Chlamydia, Trichomonas, Gardnerella, and Neisseria Gonorrhoeae are all sexually transmitted infections that can cause vaginal discharge, but they are less likely in this case given the recent dental procedure and antibiotic use. Candida is the most likely culprit in this scenario.

Treatment for a vaginal yeast infection typically involves antifungal medications, either in the form of creams or oral tablets. It is important for the patient to follow up with their healthcare provider for proper diagnosis and treatment.

Quinolones work by inhibiting DNA gyrase, which is an enzyme that is essential for the replication and repair of bacterial DNA. By blocking the action of DNA gyrase, quinolones prevent the bacterial DNA from unwinding and duplicating, ultimately leading to the death of the bacteria. This mechanism of action is specific to quinolones and is different from other classes of antibiotics that target cell wall synthesis, RNA polymerase, protein synthesis, or folic acid metabolism. Overall, quinolones are effective in treating a wide range of bacterial infections due to their ability to interfere with bacterial DNA replication.

Among the given options, the most likely cause for the patient’s presenting symptoms is acute interstitial nephritis secondary to anti-tubercular therapy (ATT)
Drug-induced acute interstitial nephritis can occur following treatment with beta-lactams, sulphonamides, rifampicin, ethambutol, and erythromycin. They can cause an acute allergic reaction with the infiltration of immune cells.
Acute interstitial nephritis is said to be the most common renal complication in patients undergoing anti-TB treatment. Rifampicin is the most implicated drug, although ethambutol can also be a cause. The pathogenesis involves an immune-complex mediated acute allergic response, which leads to their deposition on renal vessels, the glomerular endothelium, and the interstitial area.

Other options:
Isoniazid does not affect the kidneys.
Pulmonary-renal syndrome is a feature of Goodpasture’s syndrome. It is characterized by renal failure and lung haemorrhage. Severe cardiac or renal failure ensues and is complicated by pulmonary oedema, systemic lupus erythematosus, Henoch-Schönlein purpura, and cryoglobulinemia.

The prognosis of an HIV-infected individual is primarily determined by their CD4 count and plasma HIV RNA levels. These factors indicate the progression of the disease and the effectiveness of treatment. Geographic location can also play a role in prognosis, as access to healthcare and treatment options may vary. Economic status can impact prognosis indirectly, as individuals with lower economic status may have less access to healthcare and resources. Genetic makeup can also influence how the body responds to the virus and treatment. However, dietary habits are not a significant factor in determining the prognosis of an HIV-infected individual. While a healthy diet can support overall health and immune function, it is not a direct determinant of HIV progression.

Cotrimoxazole is an antibiotic commonly used to prevent and treat infections in infants who are exposed to HIV. In the context of HIV-exposed infants, it is important to continue cotrimoxazole until it is deemed safe to stop based on certain criteria.

Cotrimoxazole should be stopped for infants when PCR (Polymerase Chain Reaction) testing is negative for HIV ≥ 6 weeks after full cessation of breastfeeding AND the infant is clinically HIV negative. This criteria ensures that the infant has not been infected with HIV and is no longer at risk of developing HIV-related infections.

Therefore, stopping cotrimoxazole in this scenario is safe and appropriate as it indicates that the infant is no longer in need of the antibiotic for HIV prevention.

Pregnant women who are newly diagnosed with HIV are recommended to immediately initiate antiretroviral therapy (ART) regardless of their CD4 count or clinical stage. This is because ART has been shown to significantly reduce the risk of mother-to-child transmission of HIV, as well as improve the health outcomes for both the mother and the baby. Delaying initiation of ART until after delivery can increase the risk of transmission to the baby and may also compromise the health of the mother. Referring the woman to a specialist for further evaluation may delay the start of treatment and potentially increase the risk of transmission. Offering supportive care without ART is not recommended as ART is the standard of care for managing HIV in pregnant women. Encouraging the woman to seek a second opinion before starting ART may also delay treatment and increase the risk of transmission. Therefore, immediate initiation of ART is the recommended action for pregnant women who are newly diagnosed with HIV.

The most likely cause of the rash and subsequent death in this pregnant female is Varicella zoster virus (VZV) infection. VZV is the virus responsible for causing chickenpox and shingles. In pregnant women, VZV infection can lead to severe complications, including pneumonitis, which is inflammation of the lungs.

The presentation of macules (flat, red spots) that progress to vesicles (fluid-filled blisters) is characteristic of VZV infection. The virus can spread throughout the body, leading to systemic symptoms and potentially fatal complications.

Chorioamnionitis is an infection of the placental tissues and amniotic fluid, which can occur during pregnancy but would not typically present with a rash and vesicles. Herpes simplex virus can also cause vesicular rash, but it is less common in pregnant women and does not typically lead to pneumonitis. Listeriosis and rubella are other infections that can cause rash, but they are less likely to present with the specific progression of macules to vesicles seen in this case.

Overall, given the clinical presentation and findings during the post-mortem examination, Varicella zoster virus (VZV) is the most likely cause of the rash and subsequent complications in this pregnant female.

When a patient is diagnosed with both TBM and cryptococcal meningitis, it is important to initiate treatment promptly to prevent further complications and improve outcomes. Both conditions are serious infections that require immediate attention.

In this scenario, the best approach would be to treat both conditions simultaneously. There is no specific guideline indicating which infection should be treated first, but it is common practice to start treatment for both infections at the same time. This approach ensures that both infections are addressed promptly and effectively.

After initiating treatment for TBM and cryptococcal meningitis, it is recommended to wait for 6-8 weeks before starting antiretroviral therapy (ART). This waiting period allows for the initial treatment of the infections to take effect and stabilize the patient before introducing ART. Starting ART too soon can potentially worsen the symptoms of the infections or lead to complications.

Overall, the priority should be to treat both TBM and cryptococcal meningitis simultaneously and then initiate ART after the initial treatment has had time to work. This approach can help improve the patient’s overall health and reduce the risk of complications.

PrEP, or pre-exposure prophylaxis, is a medication taken by individuals who are at high risk of contracting HIV to prevent infection. On-demand dosing refers to taking PrEP only around the time of potential exposure to HIV, rather than taking it daily.

The drug of choice for on-demand dosing specifically for MSM (men who have sex with men) and transgender women is TDF/FTC (tenofovir disoproxil fumarate/emtricitabine) taken 2-24 hours before sex. This combination of drugs has been shown to be highly effective in preventing HIV transmission when taken in this manner.

The HIVCS 2020 update recommends a 2:1:1 strategy with TDF/FTC for MSM and transgender women, meaning that individuals should take two pills 2-24 hours before sex, and then continue with one pill daily for the next two days. This strategy has been found to be effective in reducing the risk of HIV transmission in these populations.

It is important for individuals considering on-demand PrEP dosing to consult with a healthcare provider to determine the best regimen for their specific needs and circumstances.

Antibiotic prophylaxis is recommended for certain medical procedures to prevent infective endocarditis in patients with certain heart conditions. However, recent guidelines from the National Institute for Health and Care Excellence (NICE) have determined that patients with isolated atrial septal defects do not require antibiotic prophylaxis for dental procedures. This is because the risk of developing infective endocarditis in these patients is considered to be very low.

The other procedures listed, such as cholecystectomy, emergency sigmoid colectomy, splenectomy, and total hip replacement, may still require antibiotic prophylaxis in certain cases depending on the patient’s individual medical history and risk factors for infective endocarditis.

Tracking and managing the health of HIV-positive women and their infants is crucial in ensuring proper care and treatment. The Maternity Case Record is a comprehensive document that includes information on the mother’s medical history, antenatal care, HIV status, and treatment plan. It allows healthcare providers to monitor the progress of the pregnancy and ensure that the mother receives appropriate care.

The Road to Health Booklet is a similar document for infants, providing a record of their growth, development, immunizations, and any health concerns. It is important for tracking the infant’s health and ensuring they receive necessary medical interventions.

Using these documents in conjunction with a health diary and personal notes can provide a complete picture of the health status of both the mother and infant. Additionally, an electronic health record system can help streamline the tracking and management process by allowing for easy access to patient information and facilitating communication between healthcare providers.

In some cases, a national HIV/AIDS tracking database may also be utilized to monitor the overall health outcomes of HIV-positive women and their infants on a larger scale. By utilizing these recommended documents and systems, healthcare providers can effectively track and manage the health of HIV-positive women and their infants to ensure the best possible outcomes.

Hepatitis C treatment in people living with HIV is a complex issue that requires careful consideration of various factors. One of the true statements about hepatitis C treatment in people living with HIV is that newer all-oral direct-acting antiviral HCV regimens (DAAs) have fewer drug-drug interactions than earlier interferon-based regimens. This is important because people living with HIV often take multiple medications, and minimizing drug interactions is crucial to avoid potential complications and ensure the effectiveness of treatment. By using newer DAAs, healthcare providers can more easily manage drug interactions and provide safer and more effective treatment for HIV/HCV coinfected patients.

Enhanced Adherence Counselling (EAC) is a specialized form of counseling aimed at individuals who are struggling with adhering to their treatment regimen, particularly in the context of HIV/AIDS treatment. The purpose of EAC, as outlined in the guidelines, is to address issues with adherence to treatment and develop strategies to overcome barriers that may be hindering the individual’s ability to consistently take their medication as prescribed.

The options provided in the question highlight the importance of EAC in providing education, support, and guidance to individuals who may be experiencing challenges with adherence. While EAC does involve educating clients about the side effects of antiretroviral therapy (ART) and monitoring viral load, its primary focus is on addressing adherence issues and developing strategies to improve treatment adherence.

Disease state vs Serology
Acute hepatitis: HBsAg, HBeAg, anti-HBc IgM
Chronic hepatitis B (low infectivity): HBsAg (>6/12), anti-HBe, anti-HBc IgG
Chronic hepatitis B (high infectivity): HBsAg (>6/12), HBeAg, anti-HBc IgG
Cleared infection: Anti-HBs, anti-HBe, anti-HBc IgG
Vaccinated: Anti-HBs

Nevirapine (NVP) is an antiretroviral medication used to treat HIV/AIDS in infants. The dosing recommendation for infants aged birth to 6 weeks and weighing between 2.0 to 2.49 kg is 1 ml (10 mg) once daily. This dosage is based on the weight of the infant and is important to ensure the medication is effective and safe for the child.

The conditions that need to be notified to the consultant responsible for communicable disease control are typically those that are highly contagious and have the potential to spread rapidly within a community. Pneumococcal pneumonia, Pneumococcal meningitis, Campylobacter food poisoning, E. coli H0157 food poisoning, and Vivax malaria are all conditions that fall into this category.

However, Vivax malaria does not belong to the list of diseases that need to be notified to relevant authorities to prevent or reduce their spread. While malaria is a serious and potentially life-threatening disease, it is not considered highly contagious in the same way as the other conditions listed. Malaria is primarily spread through the bite of an infected mosquito and does not typically spread directly from person to person.

Therefore, Vivax malaria is the condition that does not belong to the category of diseases that need to be notified to the consultant responsible for communicable disease control.

Hepatitis B is a viral infection that can be transmitted through exposure to infectious blood or body fluids. Perinatal transmission, which occurs around the time of birth or through contact with infected blood during childhood, is the most common route of transmission worldwide. In areas where hepatitis B is common, the virus is often passed from mother to child during childbirth, with a 20% risk of transmission if the mother is positive for HBsAg. This risk increases to 90% if the mother is also positive for HBeAg. In areas where hepatitis B is rare, intravenous drug use and sexual intercourse are more common routes of transmission. Overall, perinatal transmission is the most common route of hepatitis B transmission globally.